Mycosis fungoides and Sezary syndrome: New pathogenetic aspects [Aktuelle aspekte zur pathogenese von Sézary-syndrom und mycosis fungoides]

被引:0
|
作者
Dummer R. [1 ]
Willers J. [1 ]
Döbbeling U. [1 ]
Burg G. [1 ]
机构
[1] Universitätsspital Zürich, Dermatologische Klinik, Zürich
来源
Der Hautarzt | 2001年 / 52卷 / 3期
关键词
Cutaneous T-cell lymphoma; Cytokines; Interferon; Interleukin-15; Mycosis fungoides; Sézary syndrome;
D O I
10.1007/s001050051288
中图分类号
学科分类号
摘要
Cutaneous T-cell lymphomas are a heterogeneous group of lymphoproliferative skin disorders whose pathogenesis is poorly understood. Cytokines and chemokines are important factors which can modify the cutaneous microenvironment allowing the accumulation of lymphocytes. Most of these neoplasms seem to be T helper-2 cells. While interferon gamma is the natural inhibitor of clonal T-cell proliferations, interferon resistance has been recently found in these cells. This interferon resistance may be an Achilles heel that can be targeted by molecular therapeutic interventions.
引用
收藏
页码:189 / 192
页数:3
相关论文
共 50 条
  • [41] Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment
    Fujii, Kazuyasu
    Yoshizaki, Ai
    Matsuoka, Atsuko
    Baba, Naoko
    Ohshima, Koichi
    Kanekura, Takuro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (03) : 294 - 296
  • [42] Selected soluble biomarkers in mycosis fungoides and Sezary syndrome: Final results of S-MISR trial
    Elsayad, K.
    Bormann, K.
    Nawar, T.
    Rolf, D.
    Mueller, E. C.
    Pepper, N. B.
    Weishaupt, C.
    Hillmann, H.
    Bormann, E.
    Steinbrink, K.
    Greve, B.
    Eich, H. T.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S798 - S799
  • [43] Galenus von Pergamon Prize 2021-the Candidates Poteligeo® slows Tumor Progression in Mycosis fungoides and Sezary Syndrome
    不详
    ONKOLOGE, 2021, 27 (09): : 910 - 910
  • [44] Galenus von Pergamon Prize 2021-the Candidates Poteligeo® slows Tumor Progression in Mycosis Fungoides and Sezary Syndrome
    不详
    HAUTARZT, 2021, 72 (10): : 899 - 899
  • [45] Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients
    Gandham, Ashley R.
    Geller, Shamir
    Dusza, Stephen W.
    Kupper, Thomas S.
    Myskowski, Patricia. L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e174 - e180
  • [46] Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sezary Syndrome
    Quaglino, Pietro
    Fava, Paolo
    Pileri, Alessandro
    Grandi, Vieri
    Sanlorenzo, Martina
    Panasiti, Vincenzo
    Guglielmo, Alba
    Alberti-Violetti, Silvia
    Novelli, Mauro
    Astrua, Chiara
    Rubatto, Marco
    Tonella, Luca
    Berti, Emilio
    Pimpinelli, Nicola
    Abate, Simona Osella
    Fierro, Maria Teresa
    Vermeer, Maarten
    Scarisbrick, Julia J.
    Ribero, Simone
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (03) : 484 - 495
  • [47] Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study
    Belfrage, Emma
    Sara, E. K.
    Johansson, Asa
    Brauner, Hanna
    Sonesson, Andreas
    Drott, Kristina
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [48] Mycosis fungoides and Sézary syndrome - Simplifying the approach for dermatologists. Part 1: Etiopathogenesis, clinical features and evaluation
    Singh, Gautam Kumar
    Das, Pankaj
    Sharma, Pragya
    Srivastava, Shailendra
    Singh, Vikram
    Singh, Kanwaljeet
    Barui, Sanghita
    Mulajkar, Deepak
    Dubey, Indra Prakash
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2025, 91 (01): : 40 - 48
  • [49] Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998–2016
    Jaana Keto
    Sonja Hahtola
    Miika Linna
    Liisa Väkevä
    BMC Health Services Research, 21
  • [50] Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
    Alessandro Pileri
    Cinzia Pellegrini
    Claudio Agostinelli
    Vieri Grandi
    Annalisa Patrizi
    Pier Luigi Zinzani
    Nicola Pimpinelli
    European Journal of Dermatology, 2017, 27 : 49 - 53